8-K: VerifyMe Faces Nasdaq Delisting Risk Over Share Price

VerifyMe, Inc. has received a formal notice from Nasdaq regarding its failure to maintain the minimum $1.00 bid price requirement for continued listing.

Summary

• A deficiency letter was received from Nasdaq on April 17, 2026, regarding the company's share price.
• The common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days.
• An initial compliance period of 180 calendar days has been granted to rectify the deficiency.
• To regain compliance, the stock must close at $1.00 or higher for at least 10 consecutive business days.
• The deadline to meet the requirement is October 14, 2026.
• A second 180-day extension may be available if the company meets other listing standards.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development as it introduces regulatory risk and the potential for a dilutive or sentiment-damaging reverse stock split.

Positives

• The notification has no immediate effect on the listing or trading of the common stock on the Nasdaq Capital Market.
• A significant grace period of 180 days provides ample time for management to implement a recovery strategy.
• The company may qualify for an additional 180-day extension if it meets market value requirements for publicly held shares.

Negatives

• The stock has consistently traded below the $1.00 threshold for over a month.
• Failure to regain compliance will lead to a delisting notice from Nasdaq.
• The deficiency reflects a period of sustained low market valuation and potential investor skepticism.

Risks

• Risk of delisting from the Nasdaq Capital Market if the $1.00 bid price is not achieved by October 14, 2026.
• Potential loss of liquidity and limited access to capital markets if the stock moves to over-the-counter (OTC) trading.
• Market volatility may prevent the stock from maintaining the required price for the 10-day minimum period.

Future Outlook

Management intends to monitor the closing bid price and consider available options to regain compliance, which may include organic growth strategies or corporate actions such as a reverse stock split.

Management Comments

• The Company intends to monitor the closing bid price of its common stock and consider its available options.
• There can be no assurance that actual results will not differ materially from what the Company expects or believes.

Industry Context

StockSavvy.ai notes that micro-cap companies frequently encounter minimum bid price deficiencies during broader market downturns; such entities often resort to reverse stock splits to maintain their primary exchange listings and institutional visibility.

Comparison to Industry Standards

• The $1.00 minimum bid price is a universal requirement for all companies listed on the Nasdaq Capital Market.
• The 180-day cure period is the standard regulatory response for this specific type of listing deficiency.
• Similar notices have been issued to other micro-cap technology firms such as Akanda Corp and Blue Star Foods when market capitalizations compressed.

Stakeholder Impact

• Shareholders face the risk of reduced liquidity and potential delisting to OTC markets.
• Investors may see a reverse stock split in the near future, which often impacts short-term trading sentiment.

Next Steps

• Monitor daily closing bid prices to track progress toward the 10-day compliance window.
• Evaluate the necessity of a reverse stock split to artificially increase the share price.
• Prepare for a potential appeal to the Nasdaq hearings panel if compliance is not met by the deadline.

Key Dates

Recommendation

While the delisting notice is a negative signal, the company has a full six months to rectify the situation. Current investors should hold to see if management can drive organic recovery or if a reverse split is announced, but new positions should be avoided until compliance is regained.

Keywords

Nasdaq Delisting, Minimum Bid Price, VerifyMe Inc, VRME, Listing Deficiency, Nasdaq Capital Market, Securities Compliance